lan.png
EN
search.png
{$ImageUrl,alt}
Blog
home.png Home>Blog
更换7.jpg
2024.12.03
Comprehensive Analysis of Liposome Types: Diversified Solutions for Vaccine Delivery
Comprehensive Analysis of Liposome Types: Diversified Solutions for Vaccine DeliveryLiposomes, as crucial carriers for vaccine delivery, possess unique structural and functional characteristics that enable them to meet the complex needs of various vaccines. Fr...
更换6.jpg
2024.12.03
Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma
Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma In May 2024, the U.S. Food and Drug Administration (FDA) announced the approval of irinotecan lipos...
20241212160900639.png
2024.12.03
mRNA Vaccines and Lipid Nanoparticle Lyophilization Technology: Breakthroughs in Innovative Delivery Systems in Vaccine Development
mRNA Vaccines and Lipid Nanoparticle Lyophilization Technology: Breakthroughs in Innovative Delivery Systems in Vaccine Development Driven by the COVID-19 pandemic, mRNA vaccines and lipid nanoparticle (LNP) delivery systems have become key technologies i...
磁性纳米颗粒5.jpg
2025-01-14
Litchlab Launches Innovative Targeted Drug Delivery Platform: Precision Treatment Through Surface-Modified Liposomes
January 2025 – Litchlab, a leading biotechnology company focused on liposome drug delivery technology, has announced the official launch of its groundbreaking targeted drug delivery platform. This platform leverages surface-modified liposomes to precisely targ...
纳米载体5.jpg
2025-01-14
​Litchlab: A Leader in Targeted Liposome Drug Delivery Technology
In the field of drug delivery, liposome technology has become a critical therapeutic tool, especially with its application in targeted drug delivery systems. As the demand for targeted therapies continues to rise, the potential of liposomes as drug carriers is...
更换4.jpg
2024-11-06
A New Era in Delivery: Our Liposome Technology Supports the Future of Drug and Vaccine Development
A New Era in Delivery: Our Liposome Technology Supports the Future of Drug and Vaccine Development   In the modern biopharmaceutical field, efficient delivery technology is a key factor in determining the success of treatments. Our company focuses on...
更换2.jpg
2024-11-06
Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma
Breakthrough of Liposome Technology in Cancer Therapy: FDA Approval of Irinotecan Liposome for First-Line Treatment of Metastatic Pancreatic Adenocarcinoma In May 2024, the U.S. Food and Drug Administration (FDA) announced the approval of irinotecan lipos...
更改3.jpg
2024-11-06
Key Role and Application Prospects of Liposomes in Vaccines
Key Role and Application Prospects of Liposomes in Vaccines  In recent years, liposome technology has garnered significant attention in the vaccine field, particularly in the development of COVID-19 vaccines, where liposomes have served as a core technolo...
更换5.jpg
2024-12-03
Breakthrough in New mRNA Vaccine Liposomes
Breakthrough in New mRNA Vaccine Liposomes In June 2024, BioTechPharma, a global leader in biopharmaceuticals, announced that its innovative mRNA vaccine liposome carrier has successfully entered the clinical trial phase. The vaccine, developed to target a nov...
上一页 89101112 下一页